Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav–Related Liver Injury

Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav–Related Liver Injury

Background: Idiosyncratic drug-induced liver injury (DILI) is a serious uncommon disease that may develop as a result of the intake of certain drugs such as the antimicrobials flucloxacillin and co-amoxiclav. The reported cases showed significant associations between DILI and various human leukocyte...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Mohammad Alshabeeb, Fadhel A. Alomar, Amjad Khan
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2022-06-01
Seri Bilgileri:Frontiers in Pharmacology
Konular:
SLCO1B1
DILI
flucloxacillin
co-amoxiclav
liver injury
pharmacogenetics
Online Erişim:https://www.frontiersin.org/articles/10.3389/fphar.2022.882962/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.882962/full

Benzer Materyaller